On August 13, Responsum Health announced its commitment to building a new patient platform for uterine fibroids—a devastating and under-recognized chronic condition that affects the lives of millions of women, both in the U.S. and worldwide. In
We use cookies to improve your browsing experience, serve personalized ads or content, and analyze our traffic. By clicking “Accept All”, you consent to our use of cookies.
Cookies are small bits of information that we might place on your computer. We use them to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
You can program your computer to warn you each time a cookie is being sent, block third party cookies or block all cookies. However, by blocking all cookies you may not have access to certain features of the service. To learn more visit our Privacy Policy page.
